Director Melissa B. Epperly filed a Form 4 with the SEC on October 27, 2026, reporting two transactions in Roivant Sciences Ltd. common shares dated October 23, 2026, related to the company's Non-Employee Director Compensation Plan.

Key Highlights

  • Award received: Epperly acquired 513 common shares on October 23, 2026, at a price of $0, pursuant to Roivant Sciences Ltd.'s Non-Employee Director Compensation Plan, fully vested as of the grant date.
  • Tax withholding settlement: 116 common shares were disposed of on October 23, 2026, at $36.49 per share via net settlement to satisfy applicable tax withholding obligations.
  • Resulting ownership: Following both transactions, Epperly directly beneficially owned 15,351 common shares.
  • Reporting person role: Epperly is identified in the filing as a Director of Roivant Sciences Ltd.
  • Filing signed by: Sam Kaplan, as Attorney-in-Fact for Melissa Epperly, on October 27, 2026.

Roivant Director Epperly's October 2026 Share Award and Net Settlement Details

According to the filing, Melissa B. Epperly received an award of 513 common shares of Roivant Sciences Ltd. (NASDAQ:ROIV) on October 23, 2026, at a price of $0. The filing states that this award was made "pursuant to the Issuer's Non-Employee Director Compensation Plan" and "was fully vested as of the grant date." Following this acquisition, her directly held beneficial ownership stood at 15,467 shares.

Also on October 23, 2026, the filing reports that 116 common shares were disposed of at a price of $36.49 per share. The filing describes this as a "net settlement" by the issuer of common shares previously granted to Epperly "in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such Common Shares." This transaction carried transaction code F, consistent with shares withheld for taxes.

After both transactions were recorded, Epperly's direct beneficial ownership of Roivant Sciences Ltd. common shares totaled 15,351 shares, according to the filing. No derivative securities were reported in Table II of the form. The filing was made by one reporting person and was not identified as an amendment to a prior filing.

What Was Disclosed

The filing discloses a director share award of 513 common shares at $0 and a net settlement disposal of 116 shares at $36.49 for tax withholding purposes, both on October 23, 2026, leaving Epperly with 15,351 directly owned shares.